Rx spending to grow 5.2% next year: CMS

Share this article:

The Affordable Care Act is expected to give drugmakers a big boost, a recent government forecast shows. The forecast, issued by the Centers for Medicare and Medicaid Services (CMS) and analyzed by Pharmalot, shows projected prescription drug spending is poised to grow 5.2% in 2014, vs. 0.6% growth in 2013 and vs. an 0.8% drop in spending in 2012.

Without the anticipated stimulus from Obamacare, prescription-drug spending would be 2.9% lower in 2014, the blog points out, suggesting "a clear benefit."

Of course, some drugmakers are likely to receive a bigger shot in the arm than others, but over time, CMS predicts the overall benefit will grow due to price hikes and wider utilization, translating into a 6.5% annual incrase in spending from from 2015 through 2022, due to a plateau in generic dispensing, a pick-up in income growth and earlier prescribing to an aged population.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.